RAS Inhibitors for Pancreatic Cancer: What to Know
New medicines called RAS inhibitors are dramatically changing the way pancreatic cancer will be treated over the coming years. They are a beacon of hope for patients with the disease. There are several oral RAS inhibitors for pancreatic cancer in late phase clinical trials, including one that has been given an initial regulatory green light … Read more